Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
311.56 USD | +0.42% | +0.23% | +17.41% |
Dec. 04 | Morgan Stanley Raises Intuitive Surgical Price Target to $330 From $300, Maintains Equal Weight Rating | MT |
Nov. 21 | It’s Nvidia Day | ![]() |
Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows:
- sale of instruments and accessories (56.5%): primarily wrist cuffs;
- sale of robotic systems (27%): systems marketed under the da Vinci brand (1,264 units sold in 2022) and intended primarily for urological, cardio-thoracic, and gynecological surgeries;
- installation and training services (16.5%).
The United States accounts for 66.8% of net sales.
Calendar
2024-01-24
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
311.56USD
Average target price
327.83USD
Spread / Average Target
+5.22%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.41% | 109 B $ | |
-10.28% | 191 B $ | |
-17.52% | 163 B $ | |
+18.93% | 80 310 M $ | |
+11.71% | 63 346 M $ | |
-10.43% | 47 620 M $ | |
-8.51% | 42 146 M $ | |
-14.01% | 37 658 M $ | |
+15.43% | 30 979 M $ | |
-21.45% | 24 121 M $ |
- Stock
- Equities
- Stock Intuitive Surgical, Inc. - Nasdaq
- News Intuitive Surgical, Inc.
- Raymond James Adjusts Price Target on Intuitive Surgical to $368 From $323, Maintains Outperform Rating